Management of Infections in the Immunocompromised Host

Comprehensive in scope

Written by experts in the field

Includes conference-style case studies

Introduces new advances in therapy

Comprehensive in scope Written by experts in the field Includes conference-style case studies Introduces new advances in therapy

Autorentext

Dr. Brahm Segal is currently the Vice Chair of Faculty Development at the University of Buffalo School of Medicine and Chief of the Division of Infectious Diseases at Roswell Park Cancer Institute. He earned his medical degree at Albert Einstein College of Medicine before completing his residency at Tufts New England Medical Center. He completed a fewllowship in infectious diseases at the National Institute for Allergy and Infectious Diseases and has dedicated himself to treating patients, lecturing, educating clinical trainees, and researching host defenses through his nationally funded translational research program. Dr. Segal has been honored with a multitude of awards, including Best Doctor and Top Doctor in 2011.

Zusammenfassung

Comprehensive in scope

Written by experts in the field

Includes conference-style case studies

Introduces new advances in therapy

Inhalt
1.Phagocytes.- 2.T-cells.- 3.B cell Immunity.- 4.Complement.- 5.Antimicrobial peptides.- 6.Role of Deficits in Pathogen Recognition Receptors in Infection Susceptibility.- 7.Defects of Innate Immunity.- 8.T Cell Defects.- 9.Inflammatory Bowel Disease in Primary Immunodeficiencies.- 10.Infections in Cancer.- 11.Infections in Hematopoietic Stem Cell Transplant Recipients.- 12.Infections in Solid Organ Transplant Recipients.- 13.Infections in HIV infected patients.- 14.Infections in Patients with Autoimmune Diseases.- 15.Antibacterials and antifungals: The Challenges of Antibiotic-Resistant Infections in the Immunocompromised Host.- 16.Antiviral treatment and prophylaxis in immunocompromised hosts.- 17.Role of Immunoglobulin Therapy to Prevent and Treat Infections.- 18.Vaccination of Immunocompromised Patients.- 19..Stem Cell Transplantation for Primary Immunodeficiency.- 20.Specific Adoptive T-cell Therapy for Viral and Fungal Infections.- 21.Gene Therapy for Primary Immunodeficiencies.